🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Sarah Ketterer’s BMY Holdings & Trades

First Buy
Q2 2024
Duration Held
4 Quarters
Largest Add
Q2 2024
+727,352 Shares
Current Position
3,673 Shares
$229,195 Value

Sarah Ketterer's BMY Position Overview

Sarah Ketterer (via Causeway Capital Management LLC) currently holds 3,673 shares of Bristol-Myers Squibb Company (BMY) worth $229,195, representing 0.00% of the portfolio. First purchased in 2024-Q2, this short-term holding has been held for 4 quarters.

Based on 13F filings, Sarah Ketterer has maintained this position in BMY for several quarters, showing initial confidence in the investment. Largest addition occurred in Q3 2024, adding 23,103 shares. Largest reduction occurred in Q4 2024, reducing 750,455 shares.

Analysis based on 13F filings available since 2013 Q2

Sarah Ketterer's Bristol-Myers Squibb Company (BMY) Holding Value Over Time

Track share changes against reported price movement

Quarterly Bristol-Myers Squibb Company (BMY) Trades by Sarah Ketterer

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q3 2026 +3,673 New Buy 3,673 $62.40
Q4 2024 -750,455 Sold Out 0 $0.00
Q3 2024 +23,103 Add 3.18% 750,455 $51.74
Q2 2024 +727,352 New Buy 727,352 $41.53

Sarah Ketterer's Bristol-Myers Squibb Company Investment FAQs

Sarah Ketterer first purchased Bristol-Myers Squibb Company (BMY) in Q2 2024, acquiring 727,352 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Sarah Ketterer has held Bristol-Myers Squibb Company (BMY) for 4 quarters since Q2 2024.

Sarah Ketterer's largest addition to Bristol-Myers Squibb Company (BMY) was in Q2 2024, adding 727,352 shares worth $30.21 M.

According to the latest 13F filing for Q3 2026, Sarah Ketterer's firm, Causeway Capital Management LLC, owns 3,673 shares of Bristol-Myers Squibb Company (BMY), valued at approximately $229,195.

As of the Q3 2026 filing, Bristol-Myers Squibb Company (BMY) represents approximately 0.00% of Sarah Ketterer's publicly disclosed stock portfolio, making it one of their key holdings.

Sarah Ketterer's peak holding in Bristol-Myers Squibb Company (BMY) was 750,455 shares, as reported at the end of Q3 2024.